255 related articles for article (PubMed ID: 28002789)
1. MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype.
Lynam-Lennon N; Heavey S; Sommerville G; Bibby BA; Ffrench B; Quinn J; Gasch C; O'Leary JJ; Gallagher MF; Reynolds JV; Maher SG
Oncotarget; 2017 Feb; 8(7):11400-11413. PubMed ID: 28002789
[TBL] [Abstract][Full Text] [Related]
2. Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma.
Lynam-Lennon N; Bibby BA; Mongan AM; Marignol L; Paxton CN; Geiersbach K; Bronner MP; O'Sullivan J; Reynolds J; Maher SG
Mol Med; 2016 May; 22():388-97. PubMed ID: 27254108
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma.
Bibby BA; Reynolds JV; Maher SG
PLoS One; 2015; 10(7):e0134180. PubMed ID: 26221725
[TBL] [Abstract][Full Text] [Related]
4. Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma.
Bibby BAS; Miranda CS; Reynolds JV; Cawthorne CJ; Maher SG
BMC Cancer; 2019 Aug; 19(1):784. PubMed ID: 31391080
[TBL] [Abstract][Full Text] [Related]
5. A methyltransferase-like 14/miR-99a-5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2-mediated epigenetic modulation in esophageal squamous cell carcinoma.
Liu Z; Wu K; Gu S; Wang W; Xie S; Lu T; Li L; Dong C; Wang X; Zhou Y
Clin Transl Med; 2021 Sep; 11(9):e545. PubMed ID: 34586732
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma.
Lynam-Lennon N; Reynolds JV; Marignol L; Sheils OM; Pidgeon GP; Maher SG
J Mol Med (Berl); 2012 Dec; 90(12):1449-58. PubMed ID: 22706599
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.
Sun X; Martin RCG; Zheng Q; Farmer R; Pandit H; Li X; Jacob K; Suo J; Li Y
Cell Oncol (Dordr); 2018 Dec; 41(6):651-662. PubMed ID: 30116994
[TBL] [Abstract][Full Text] [Related]
8. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
9. miR-20b and miR-125a promote tumorigenesis in radioresistant esophageal carcinoma cells.
Chen D; Su H; Li Y; Wu X; Li Y; Wei C; Shi D; Gao Y; Zhou Q; Wang Q; Jin X; Xie C
Aging (Albany NY); 2021 Mar; 13(7):9566-9581. PubMed ID: 33714953
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis.
Xi S; Inchauste S; Guo H; Shan J; Xiao Z; Xu H; Miettenen M; Zhang MR; Hong JA; Raiji MT; Altorki NK; Casson AG; Beer DG; Robles AI; Bowman ED; Harris CC; Steinberg SM; Schrump DS
Oncogene; 2015 Oct; 34(44):5548-59. PubMed ID: 25703328
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-181b-5p, ETS1, and the c-Met pathway exacerbate the prognosis of pancreatic ductal adenocarcinoma after radiation therapy.
Tomihara H; Yamada D; Eguchi H; Iwagami Y; Noda T; Asaoka T; Wada H; Kawamoto K; Gotoh K; Takeda Y; Tanemura M; Mori M; Doki Y
Cancer Sci; 2017 Mar; 108(3):398-407. PubMed ID: 28064436
[TBL] [Abstract][Full Text] [Related]
12. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
[TBL] [Abstract][Full Text] [Related]
13. c-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis.
Zhang L; Wang X; Li Y; Han J; Gao X; Li S; Wang F
Clin Transl Med; 2021 Sep; 11(9):e464. PubMed ID: 34586738
[TBL] [Abstract][Full Text] [Related]
14. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
Matsuzaki J; Suzuki H; Tsugawa H; Watanabe M; Hossain S; Arai E; Saito Y; Sekine S; Akaike T; Kanai Y; Mukaisho K; Auwerx J; Hibi T
Gastroenterology; 2013 Dec; 145(6):1300-11. PubMed ID: 23933602
[TBL] [Abstract][Full Text] [Related]
15. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
[TBL] [Abstract][Full Text] [Related]
16. The miR-34a-5p-c-MYC-CHK1/CHK2 Axis Counteracts Cancer Stem Cell-Like Properties and Enhances Radiosensitivity in Hepatocellular Cancer Through Repression of the DNA Damage Response.
Zhao X; Zhuang Y; Wang B; Yuan B; Du S; Zeng Z
Radiat Res; 2023 Jan; 199(1):48-60. PubMed ID: 36445955
[TBL] [Abstract][Full Text] [Related]
17. miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.
Mukohyama J; Isobe T; Hu Q; Hayashi T; Watanabe T; Maeda M; Yanagi H; Qian X; Yamashita K; Minami H; Mimori K; Sahoo D; Kakeji Y; Suzuki A; Dalerba P; Shimono Y
Cancer Res; 2019 Oct; 79(20):5151-5158. PubMed ID: 31416845
[TBL] [Abstract][Full Text] [Related]
18. [Expression profiles of microRNAs in radioresistant esophageal cell line].
Zheng ZF; Su HF; Zou Y; Peng Z; Wu SX
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(9):639-42. PubMed ID: 21600139
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the unique microRNA signature in human esophageal adenocarcinoma.
Saad R; Chen Z; Zhu S; Jia P; Zhao Z; Washington MK; Belkhiri A; El-Rifai W
PLoS One; 2013; 8(5):e64463. PubMed ID: 23724052
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitizing effects of miR-18a-5p on lung cancer stem-like cells via downregulating both ATM and HIF-1α.
Chen X; Wu L; Li D; Xu Y; Zhang L; Niu K; Kong R; Gu J; Xu Z; Chen Z; Sun J
Cancer Med; 2018 Aug; 7(8):3834-3847. PubMed ID: 29860718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
